We are live on ! Find out more
KM

Kalos Management Portfolio holdings

AUM $46.6M
1-Year Est. Return 11.52%
This Fund
S&P 500
This Quarter Est. Return
+1.92%
1 Year Est. Return
+11.52%
3 Year Est. Return
+48.48%
5 Year Est. Return
+71.6%
10 Year Est. Return
AUM
$354M
AUM Growth
+$107M
Cap. Flow
+$84.6M
Cap. Flow %
23.93%
Top 10 Hldgs %
35.1%
Holding
337
New
70
Increased
96
Reduced
119
Closed
45

Top Buys

Rank Stock Value
1
BILL icon
BILL Holdings
BILL
+$13.5M
2
FSK icon
FS KKR Capital
FSK
+$11.1M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$5.23M
4
AAPL icon
Apple
AAPL
+$2.21M
5
IVW icon
iShares S&P 500 Growth ETF
IVW
+$1.95M

Sector Composition

Rank Sector Weight
1 Technology 14.99%
2 Financials 10.5%
3 Healthcare 5.03%
4 Communication Services 5.03%
5 Consumer Discretionary 4.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VKQ icon
251
Invesco Municipal Trust
VKQ
$541M
$177K 0.05%
13,300
+200
+2% +$2.76K
BTAQ
252
DELISTED
Burgundy Technology Acquisition Corporation Class A Ordinary shares
BTAQ
$177K 0.05%
17,861
+500
+3% +$4.94K
LILM
253
DELISTED
Lilium N.V. Class A Ordinary Shares
LILM
$176K 0.05%
+17,650
New +$186K
SACH
254
Sachem Capital Corp
SACH
$39.1M
$140K 0.04%
+24,236
New +$123K
SVOKU
255
DELISTED
Seven Oaks Acquisition Corp. Unit
SVOKU
$123K 0.03%
+11,900
New +$123K
ACHR icon
256
Archer Aviation
ACHR
$3.54B
$122K 0.03%
+15,938
New +$145K
USA icon
257
Liberty All-Star Equity Fund
USA
$1.79B
$120K 0.03%
+14,147
New +$123K
NLY icon
258
Annaly Capital Management
NLY
$17.1B
$111K 0.03%
3,226
+154
+5% +$5.3K
NNDM
259
Nano Dimension
NNDM
$316M
$107K 0.03%
18,212
AVPT icon
260
AvePoint
AVPT
$2.76B
$105K 0.03%
+12,100
New +$120K
BNGO icon
261
Bionano Genomics
BNGO
$12.3M
$101K 0.03%
31
+4
+15% +$14K
CLVS
262
DELISTED
Clovis Oncology, Inc.
CLVS
$101K 0.03%
23,000
-750
-3% -$3.61K
DM
263
DELISTED
Desktop Metal, Inc.
DM
$92K 0.03%
+1,180
New +$102K
BGRY
264
DELISTED
Berkshire Grey, Inc. Class A Common Stock
BGRY
$83K 0.02%
+12,000
New +$103K
AMRN
265
Amarin Corp
AMRN
$299M
$79K 0.02%
873
+120
+16% +$11.8K
PRTK
266
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$77K 0.02%
15,550
-4,000
-20% -$22K
VSTM icon
267
Verastem
VSTM
$510M
$70K 0.02%
2,021
-83
-4% -$3.05K
CTEV
268
Claritev Corp
CTEV
$387M
$67K 0.02%
316
-10
-3% -$2.71K
GYRE icon
269
Gyre Therapeutics
GYRE
$641M
$58K 0.02%
2,228
-93
-4% -$3.06K
CRNT icon
270
Ceragon Networks
CRNT
$197M
$35K 0.01%
10,550
SNMP
271
DELISTED
Evolve Transition Infrastructure LP
SNMP
$27K 0.01%
684
-17
-2% -$587
AGRX
272
DELISTED
Agile Therapeutics
AGRX
$15K ﹤0.01%
9
-1
-10% -$2.26K
ARKQ icon
273
ARK Autonomous Technology & Robotics ETF
ARKQ
$1.9B
-2,559
Closed -$215K
BBWI icon
274
Bath & Body Works
BBWI
$4.06B
-5,304
Closed -$263K
DVN icon
275
Devon Energy
DVN
$52.1B
-11,659
Closed -$312K

Similar funds

Kalos Management's Q3 2021 Portfolio in Review

As of Q3 2021, Kalos Management held 337 positions worth $354M, up 43% from $246M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Kalos Management deployed $84.6M of net new capital in Q3 2021, opening 70 new positions and adding to 96 existing holdings. Its largest new stake was BILL Holdings: 58,298 shares worth $19.9M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares Global Tech ETF, an estimated $5.03M trimmed.

  • Kalos Management's largest Q3 2021 buy was BILL Holdings: 58,298 shares worth $19.9M.
  • Kalos Management added most to FS KKR Capital in Q3 2021, an estimated $11.1M increase.
  • Kalos Management's biggest Q3 2021 reduction was iShares Global Tech ETF, cutting an estimated $5.03M.
  • Kalos Management fully exited Takeda Pharmaceutical in Q3 2021, selling an estimated $2.09M.
  • Kalos Management's ten largest holdings make up 35% of its $354M portfolio in Q3 2021.
  • Kalos Management opened 70 new positions and closed 45 in Q3 2021.
  • Kalos Management's portfolio value rose 43% quarter-over-quarter to $354M.

Based on Kalos Management's 13F filing for Q3 2021, filed 10 Nov 2021.